Search - tctmd.com

Displaying 1 - 20 of 23

Sort: Relevancy | Date

News Conference News TCT 2019

TICAKOREA: Ticagrelor Ups Bleeding Over Clopidogrel in Korean ACS Patients

Todd Neale

October 03, 2019

News Daily News TCT 2019

BLADE-PCI: Antirestenotic Drug Flops in Diabetics, but Inflammation Hypothesis Lives On

L.A. McKeown

October 02, 2019

News Conference News TCT 2019

GLOBAL LEADERS Post Hoc: Okay to Drop Aspirin After 1 Month in ACS Patients?

Todd Neale

September 30, 2019

News Conference News TCT 2019

Ultrathin-Strut Orsiro Stent as Good as BioMatrix: BIODEGRADE

Michael O'Riordan

September 30, 2019

Off Script: A (Not So) Brief History of Aspirin’s Rise and Fall

News Opinion Off Script TCT 2019

Off Script: The TWILIGHT of Aspirin? A Brief History of ASA’s Rise and Fall

Kwan S. Lee

September 29, 2019

Presentation TCT 2019

STOPDAPT, SMART-CHOICE, and TWILIGHT: Will These Trials Change Your Clinical Practice?

Presenter: Aditya Kapoor

September 28, 2019

Presentation TCT 2019

PENDULUM Registry: Relationship Between Platelet Reactivity and 1-Year Ischemic and Bleeding Outcomes After PCI

Presenter: Masato Nakamura

September 28, 2019

Presentation TCT 2019

STOPDAPT-2 HBR: 1-Year Outcomes From a Randomized Trial of Clopidogrel Monotherapy vs. DAPT Beginning 1 Month After PCI in Patients at High Bleeding Risk

Presenter: Hirotoshi Watanabe

September 28, 2019

Presentation TCT 2019

AUGUSTUS: Hospitalizations From a 2x2 Factorial Randomized Trial of Apixaban vs. Warfarin and Aspirin vs. Placebo in Patients With Atrial Fibrillation

Presenter: Amit Vora

September 28, 2019

Presentation TCT 2019

TICAKOREA: A Randomized Trial of Ticagrelor vs. Clopidogrel in Korean Patients With Acute Coronary Syndromes Intended for Invasive Management

Presenter: Duk-Woo Park

September 28, 2019

Presentation TCT 2019

Emergent Drugs and Local Drug Delivery Systems

Presenter: Juan Granada

September 28, 2019

Presentation TCT 2019

DISRUPT CAD II: A Single-Arm Study of Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Stenoses

Presenter: Carlo Di Mario

September 27, 2019

Presentation TCT 2019

TIRATROP: A Double-Blind Randomized Trial of Ticagrelor in Patients Undergoing High-Speed Rotational Atherectomy

Presenter: Thibault Lhermusier

September 27, 2019

Presentation TCT 2019

SECURE-PCI: 1-Year Outcomes From a Randomized Trial of a Loading Dose of Atorvastatin in Patients With ACS and Planned PCI

Presenter: Otavio Berwanger

September 27, 2019

Presentation TCT 2019

GLOBAL LEADERS: Ticagrelor Monotherapy vs. DAPT After PCI in TWILIGHT-Like Patients

Presenter: Yoshinobu Onuma

September 27, 2019

Presentation TCT 2019

Clinical Insights: The Evidence and Technique Behind Orbital Atherectomy

Presenter: Ajay Kirtane

September 27, 2019

Presentation TCT 2019

Clinical Trial Design in HBR Patients: Should Risk Scores Be Incoporated?

Presenter: Davide Capodanno

September 27, 2019

News Conference News TCT 2019

Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT

Caitlin E. Cox

September 26, 2019

News TCT 2019

TCT 2019 Day One: TWILIGHT and Onyx ONE Kick Things Off

Shelley Wood

September 26, 2019

News Conference News TCT 2019

AUGUSTUS: Apixaban-Based Dual Therapy Best Across Major Subgroups

Todd Neale

September 26, 2019

Advertisement

TICAKOREA: Ticagrelor Ups Bleeding Over Clopidogrel in Korean ACS Patients

BLADE-PCI: Antirestenotic Drug Flops in Diabetics, but Inflammation Hypothesis Lives On

GLOBAL LEADERS Post Hoc: Okay to Drop Aspirin After 1 Month in ACS Patients?

Ultrathin-Strut Orsiro Stent as Good as BioMatrix: BIODEGRADE

Off Script: The TWILIGHT of Aspirin? A Brief History of ASA’s Rise and Fall

STOPDAPT, SMART-CHOICE, and TWILIGHT: Will These Trials Change Your Clinical Practice?

PENDULUM Registry: Relationship Between Platelet Reactivity and 1-Year Ischemic and Bleeding Outcomes After PCI

STOPDAPT-2 HBR: 1-Year Outcomes From a Randomized Trial of Clopidogrel Monotherapy vs. DAPT Beginning 1 Month After PCI in Patients at High Bleeding Risk

AUGUSTUS: Hospitalizations From a 2x2 Factorial Randomized Trial of Apixaban vs. Warfarin and Aspirin vs. Placebo in Patients With Atrial Fibrillation

TICAKOREA: A Randomized Trial of Ticagrelor vs. Clopidogrel in Korean Patients With Acute Coronary Syndromes Intended for Invasive Management

Emergent Drugs and Local Drug Delivery Systems

DISRUPT CAD II: A Single-Arm Study of Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Stenoses

TIRATROP: A Double-Blind Randomized Trial of Ticagrelor in Patients Undergoing High-Speed Rotational Atherectomy

SECURE-PCI: 1-Year Outcomes From a Randomized Trial of a Loading Dose of Atorvastatin in Patients With ACS and Planned PCI

GLOBAL LEADERS: Ticagrelor Monotherapy vs. DAPT After PCI in TWILIGHT-Like Patients

Clinical Insights: The Evidence and Technique Behind Orbital Atherectomy

Clinical Trial Design in HBR Patients: Should Risk Scores Be Incoporated?

Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT

TCT 2019 Day One: TWILIGHT and Onyx ONE Kick Things Off

AUGUSTUS: Apixaban-Based Dual Therapy Best Across Major Subgroups

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content